Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPAS topical diclofenac for acute back or neck pain
ACTRN12626001220358Phase 4Not yet recruiting
- Sponsor
- University of Sydney
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diclofenac in Dorsalgia and cervicalgia (2 arms), sponsored by University of Sydney. Primary endpoint: Pain severity. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
diclofenac
03
Conditions
Dorsalgiacervicalgia
Beyond the preview
Go deeper on ACTRN12626001220358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626001220358.